Introduction
This paper will focus on the clinical management of the salivary hypofunction in Sjögren's syndrome. Sjögren's syndrome (SS) is a chronic inflammatory autoimmune disease that prominently affects the salivary and lacrimal glands as well as other organ systems. Within the SS category, there is a spectrum of severity of the dry mouth complaint and of associated salivary gland dysfunction. The majority of individuals with SS will complain of significant dry mouth and have extremely low salivary production. A minority of individuals with SS will have a minor complaint of dry mouth and seemingly close to normal salivary gland function. Treatment may be individualized according to the severity of the complaint of dry mouth, the level of salivary dysfunction, assessment of caries risk, and the amount of time and effort that the patient is willing to expend on their oral care.
Specific clinical practice guidelines for the oral management of Sjögren's syndrome have been developed in concert with the Sjögren's Syndrome Foundation [1] and CAMBRA guidelines [2] [3] [4] may be used for the management of individuals at high risk for dental decay, which is the majority of SS patients. One will note that almost all of the practice guidelines for oral care are not supported by a strong scientific basis. The one exception is the use topical fluoride for the prevention of dental decay [1] [2] [3] [4] [5] . As a consequence, the management of salivary hypofunction in SS could be considered more art than science, but certainly the result of decades of experience.
The sensation of dry mouth occurs when the oral tissues do not smoothly glide. The cheeks and lips stick to the teeth, the tongue gets stuck to palate, food and epithelial debris collects in nooks and crannies, clicking of mucosa can be heard during speech, and swallowing can lead to choking. The oral tissue feels parched. The liquid film thickness on the palate, in particular, has been found to be decreased in those experiencing dry mouth.
Increasing comfort for these individuals is aimed at getting the tissues to glide smoothly. Saliva has lubricant properties and its volume may be increased in the oral cavity with medication to increase flow or alter the viscosity, sucking on sugar-free hard candies, chewing on sugar free gum or "gleeking" to self-express saliva during times of need. Alternatively, an artificial saliva or use of small sips of water with or without a small amount of oil (1/4 to 1 teaspoon of olive oil or omega-3 oil to 16 oz of water, made fresh daily) may be used. The added oil aids in the movement of the oral soft tissues against the teeth and palate.
Saliva acts as an intraoral lubricant and has additional properties above and beyond providing intra-oral comfort. These functions include buffering, serving as a reservoir for molecules that can repair and protect the oral mucosa and dentition, providing volume to wash away detritus, and assisting with the act of swallowing and digestion. The loss of the ability to produce saliva is then thought to predispose to dental caries, oral infection, and difficulty with taste, swallowing, and buffering intraoral acid. The remainder of the treatment strategies for the oral component is aimed at duplicating the functions of saliva or defending against the effects of having reduced amounts of saliva.
The treatment of the oral component of SS is focused on several categories: increasing oral comfort, management of dental decay, management of oral soft tissue pathology, and stress and anxiety reduction. The treatment of the oral component of SS can be complex and time consuming for the patient and should tailored to their needs. It is beneficial if the practitioner can have a conversation with the patient with regard to when they are most dry, when they feel they want to have more saliva, and how much time they have to manage their oral dryness and potential sequelae.
Treatment Increasing salivary flow using medications
The strategies to increase salivary flow in this patient population are most effective if there is residual salivary function. A quick evaluation of this may be done on an individual who has not had anything to eat or drink within the past 2 h (small sips of water are ok). If they are not able to expectorate any saliva into a container over a 5-min period, then it is likely their salivary function is diminished to the point where trying to stimulate saliva by pharmacologic means may not be helpful, but the patient may still consider a 12-week trial.
A muscarinic agonist (pilocarpine, cevimeline, bethanechol) is recommended to increase saliva production in patients with reduced salivary function. The rationale is that increasing the amount of saliva will result in all the positive benefits that saliva provides (pH buffering, caries prevention, mucosal protection). The strength of this recommendation, however, is considered weak [1] . While the data are strong showing that muscarinic agonists increase saliva production, there are no studies showing that increasing saliva function results in decreased caries or oral infections. Stimulation of saliva with a muscarinic agonist such as pilocarpine, cevimeline, or bethanechol results in large amounts of saliva with low protein [6] . In contrast, stimulation of saliva via the sympathetic nervous system produces little saliva, but increased protein concentrate [6] . The implication is that the patient may produce a greater volume of saliva with the use of a muscarinic agonist, but it is unknown if they are actually getting more of the important, workhorse salivary constituents.
The available medications to stimulate salivary flow are dosed on a tid or qid regimen. The patient takes a pill and within 45 min, they will note increased intraoral saliva. That increased salivary function will remain elevated for another 3 to 4 h, with cevimeline having the longer duration (vs pilocarpine and bethanechol). As the salivary flow rate begins to fall after the effect of the muscarinic agonist wears off, the patient then takes another pill and the salivary flow rate is once again boosted for continuous salivary flow throughout the day. It is unknown if there are any long-term side effects from taking this medication.
Patients fall into several categories. They are either not interested in taking any systemic medication, leery of taking medication or interested in trying any medication. One also finds that these individuals may be further stratified into those who wish to have increased saliva all the time, those who only feel dry at night or upon awakening, and those who only need more saliva during meals. Thus, a patient may choose to only use medication at night or before a social/business occasion. Whatever regimen a patient chooses, I will usually have them try it for 12 weeks and then discontinue for a week to check for efficacy of the medication.
The dose of the muscarinic agonist may be titrated to the minimally effective dose to decrease the side effects (nausea, increased urination) while keeping the effect of increased salivation. With pilocarpine, the pill may be cut in half or quartered. The powder within the cevimeline capsule may be dissolved in water, but the final concentration is less precise.
The patient is informed that there are similar medications available to stimulate salivary flow and that they may need to try more than one for best results [7, 8• Increasing saliva with non-pharmacologic methods Masticatory or gustatory stimuli such as sugar-free gum or hard candies may be used to increase salivary flow to relieve oral symptoms. "Sugarless" products contain "less" sugar but remain cariogenic. Either method can provide an increase in salivary flow while the stimulus is in the mouth. The use of sugarfree chewing gum after meals has been associated with increasing the salivary film thickness, increasing clearance of food from the oral cavity, and balancing intraoral pH [13] .
"Gleeking" is a method where saliva is expressed from submandibular/ sublingual glands by self-manipulation of the tongue against the palate or front teeth. This technique is useful in those who have observable salivary pooling and do not have water or other wetting agents available.
Increasing oral comfort using wetting agents
The use of saliva substitutes are helpful in allowing the oral tissues to glide over the teeth and offers temporary comfort. The choice of a specific product is subject to individual preference. So it is important that the patient be aware that finding the right product is a trial and error process [14] . The majority of these products only provide oral comfort; they do not prevent caries (unless fluoride is added) and do not treat intraoral fungal infections.
The saliva substitute should be applied thoroughly throughout the mouth with special attention to the hard palate [13, 15••] as the liquid film thickness in this area is reduced in those with dry mouth.
The shelf space for the American market is dominated by the Biotene product-line for dry mouth. The Biotene gel ($5-8 for 1.5 oz) is more viscous than the Biotene spray (contains castor oil $6-9 for 1.5 oz). There are many other artificial salivas that have been developed for individuals who suffer from dry mouth, but are difficult to obtain and sample unless they go through a dental office, dental supply house, or internet.
Water is probably the most used wetting agent in this population. Most patients will carry a water bottle and may add a small bit of oil to their water bottle (1/4 to 1/2 teaspoon in 16 oz) to prolong the wetting effect. The oils most commonly used are olive oil or a liquid omega-3 oil purchased in the refrigerated section. Barlean's Omega Swirls ($24 for 16 oz) may be used to simultaneously add sugar-free flavor and oil to water. The patient should make their oil-water solution fresh daily and shake the bottle containing oil and water prior to sipping.
There is no strong evidence that any topical particular treatment is more effective in relieving the sensation of dry mouth [16] . The use of a topical wetting agent is a personal choice Dental caries prevention and treatment
Caries risk assessment
In general, any individual with salivary hypofunction should be considered at high risk for developing caries [2, 3] . Caries risk may be further evaluated by the presence of dry sticky mucosa (dental mirror or tongue depressor adheres to the buccal mucosa), visibly heavy plaque on the teeth, deep pits and fissures on the occlusal surface of the teeth, exposed root surface, new or recurrent caries on the areas that are considered highly cleansable (root surfaces, cusp tips, incisal edges), thick or no saliva expressed from the major salivary glands, the presence of erythematous candidiasis, glassy appearance to the oral mucosa, mucosal debris on palate, and orthodontic appliances. Other caries-promoting behaviors include frequent snacking (93 times daily between meals), recreational drug use, and the use of xerostomic medication [2, 3, 17, 18] .
Diet
Every patient should be educated on the role of dietary sugar in the promotion of caries. High risk patients should eliminate sugar (i.e., sucrose, glucose, and fructose) between meals. Between meal snacks that contain non-cariogenic sweetening agents (i.e., xylitol, sorbitol) are considered safer.
Xylitol is thought to have a role in caries prevention as it is not metabolized by cariogenic bacteria, leading to decreased acid production at the tooth surface and may contribute to a shift toward a less cariogenic bacterial population. There has been an explosion of xylitolcontaining gums, candies, and toothpastes on the market. Several guidelines [2, 3, 19] recommend ingestion of 5-6 g of xylitol per day and/or the use of a xylitol-containing toothpaste. The evidence supporting these recommendations is considered weak [20•] 
Oral hygiene
Effective plaque removal is critical to the caries prevention process. The patient should ask that their dental hygienist evaluate their brushing efficacy yearly by using a colored disclosing agent. The disclosing agents are now difficult for the individual consumer to obtain to self-assess their effectiveness. Patients will find that they will have specific areas that they will miss during brushing and those areas need to be identified.
Brushing twice daily with a soft toothbrush [21] , the use of a fluoride-containing toothpaste, and daily use of dental floss are integral to effective oral hygiene. The most critical time to remove excess dental plaque is before going to sleep as the salivary flow rates fall very close to zero. Electric toothbrushes, irrigators, interdental toothpicks/brushes, dental wipes [22•] , and supplementary dental aids are helpful.
Fluoride
Of all the recommendations for oral care, the use of fluoride has the most supportive evidence for its implementation [1-5, 23•] . The Sjögren's Syndrome Foundation Guidelines for Oral Care have recommended that topical fluoride should be used in SS patients with dry mouth [1] . The strength of the recommendation was strong. Note that the recommendation is for individuals with "dry mouth" not "salivary dysfunction." The implication is that we believe that salivary flow has fallen 40-50 % of baseline levels and some loss of protection from saliva has been lost.
Fluoride may be professionally applied or patient-applied. The SS patient with dry mouth should request a "neutral" fluoride be applied to their teeth at the dental office. The acidic product can strip the glaze from crown, composite fillings, and sealants, if present. In addition to using the 0.1 or 0.15 % fluoride in OTC toothpaste twice daily, patients should receive supplemental forms of fluoride applied to the teeth. 
Professionally applied fluoride

Root caries management
The root surface of the tooth has a higher critical pH than enamel and is considered more susceptible to the caries process than enamel. The risk for caries on the root surface is especially pronounced when the gingiva recedes and exposes the root surface. Within the armamentarium of products to manage "root caries," there are a low number of clinical trials and a high risk of bias [24] . However, the data suggest that the root caries process can be slowed or even arrested. The two products most used in this category are a 5 % fluoride varnish 2-4 times a year depending on risk [1] [2] [3] [4] [5] and the recently FDA-approved clorhexidine varnish (Cervitec, see below; [25] ).
Oral pH management
The caries process and dental erosion are pH-dependent processes. The buffering capacity is compromised in those individuals with the most severe salivary hypofunction. When a neutral or slightly basic pH cannot be maintained within mouth or on the tooth surface, the caries process can proceed unchecked. Acids may come from endogenous sources (gastric reflux, bacterial metabolism) and/or exogenous sources (carbonated beverages, sports drinks, juice, wine). To counter the effect of a sugary meal or an acidic challenge, the patient may simply rinse thoroughly with water, chew sugarfree gum immediately after, or brush their teeth to increase clearance of debris and plaque and to dilute the remaining intraoral acid. Intraoral buffering capacity may also be supplemented by the use of a bicarbonate mouth rinse (CariFree Maintenance rinse; homemade baking soda rinse with 1/2 to 1 teaspoon in 16 oz of water), toothpaste, soft chew (BasicBites®), or an extended release lozenge (Salese®).
Non-fluoride remineralizing agents
These products deliver calcium and phosphate to the tooth surface facilitating restoration of demineralized areas [26] . They are not designed to replace fluoride, but rather to enhance its function. This approach can be effective, but only after the causes of demineralization are brought under control (i.e., poor oral hygiene, acid exposure). These agents are considered an adjunct therapy in patients with SS patients with dry mouth and a high root caries rate [1] , as fluoride is considered the "gold standard" remineralizing agent [27••]. 1. Recaldent is casein phophopeptide (CPP) + amorphous calcium phosphate (APP). This product may be found in Trident Extra Care gum, MI Paste, and Meiji Milk Recaldent). MI paste is marketed with fluoride as MI Paste plus. MI paste has the advantage of having a smooth, slick feeling and is used secondarily as an oral lubricant.
Amorphous calcium phosphate. This product may be found in Arm and
Hammer Age Defying Toothpaste, Discus ACP Oral Gel, and Premier Dental Enamel Pro Polishing Paste.
3. Sensitat which is arginine bicarbonate and calcium carbonate. This product may be found in Ortek Therapeutics' Denclude and Proclude line.
4. Novamin which is calcium sodium-phosphosilicate. The availability of this product varies from one country to another. In the USA, it is available as Nupro Sensodyne Prophy paste in the dental office. Sensodyne Repair and Protect toothpaste has Novamin in the Canadian/ UK version only.
5. Tricalcium phosphate that is marketed as ClinPro5000 toothpaste.
6. Nanohydroxyapatite that is marketed as Apagard® toothpaste.
7. Calcium glycerophosphate and sodium monofluorophophate that is marketed at Spry® toothpaste and oral rinse. There is a dizzying array of interesting remineralizing agents on the market and coming to market. This is complicated by the fact that the various toothpaste recipes are periodically tweaked and re-formulated, so it can be difficult to track which toothpaste/rinse contains which product and how much of the product. In general, there is currently a lack of strong clinical data to support the use of these products [1, 28] . There is the sense that these products are not harmful and may have the potential to help [29] and may be considered as adjunct therapy in SS patients with dry mouth [1] .
Antimicrobial agents for the prevention of caries
Chlorhexidine administered by varnish, gel, or rinse may be considered in SS patients with dry mouth and root caries. The supporting evidence was deemed "weak" [1] . 
Dental restoration
In individuals with salivary hypofunction, the goal is to slow down or arrest the accelerated cycle of caries, restoration, restoration failure, and successive placement of a larger restoration until the ultimate failure resulting in extraction of the tooth. To slow down this cycle, only conservative intracoronal tooth restorations should be placed initially, with the goal of simply removing carious tooth structure and removing the minimum amount of tooth to preserve structural integrity [30] . Subgingival margins and full coronal coverage should be avoided wherever possible for initial treatment of these patients. This is because subgingival margins are the most common location of caries in individuals with salivary hypofunction. The subgingival margin is less accessible to topical fluoride and early caries is difficult to detect and restore in these areas. Full coverage crowns, if ultimately necessary, should not be placed until caries is under control (i.e., the patient has been free of new carious lesions for at least 1 year; interim restorations can be placed during the waiting period).
Treatment of oral candidiasis
The major oral soft tissue problem for which SS patients require therapy is oral candidiasis that is almost invariably of the erythematous type. These individuals will typically complain of intraoral burning that is associated with the affected mucosa (tongue, palate, buccal mucosa, denture bearing mucosa). The intraoral lesions are frequently accompanied by cracking and redness at the corners of the lips-angular cheilitis, also of fungal origin requiring therapy.
If the patient wears a denture, it will need to be treated to prevent reinfection. If there is no metal associated with the denture, it may be soaked overnight in a dilute solution of 1:10 sodium hypochlorite:water and rinsed thoroughly prior to re-insertion. If the denture contains metal, it may be soaked twice daily in a chlorehexidine solution. The denturewearing patient may also sprinkle a very fine layer of nystatin or fluconazole powder onto the WET denture surface prior to insertion into the oral cavity.
The treatment end point occurs when the mucosal erythema has resolved, the filiform papillae of the dorsal tongue will re-emerge, and the associated burning sensation has resolved. Other immune modulators and biologics
Anti-TNF agents (infliximab, etanercept), dehydroepiandrosterone, glucocorticoids, anti-CD20 (rituximab), CTLA-4 fusion protein (abatacept), and plaquenil are currently not recommended for relieving the effects of salivary hypofunction associated with Sjögren's syndrome [6, 31, 32] . There is currently
